Ocular Therapeutix (NasdaqGM:OCUL) Q3 2025 Earnings Call November 04, 2025 08:00 AM ET Company ParticipantsPravin U. Dugel - Executive Chairman, President and CEOBill Slattery - VP of Investor RelationsConference Call ParticipantsTazeen Ahmed - AnalystOperatorGood morning and welcome to the Ocular Therapeutix third quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the prepared remarks, we will conduct a question-and-answer session. To ask a question, plea ...